Global Lyme Disease Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impacts, 2015-2030 – ResearchAndMarkets.com

Global Lyme Disease Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impacts, 2015-2030 – ResearchAndMarkets.com




Global Lyme Disease Tests (In Vitro Diagnostics) Market Report 2020: Analysis and Forecast Model with COVID-19 Market Impacts, 2015-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Lyme Disease Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)” report has been added to ResearchAndMarkets.com’s offering.

The model discusses in detail the impact of COVID-19 on Lyme disease Tests market for the year 2020 and beyond. Lyme disease is an inflammatory disease caused by the bacterium Borrelia burgdorferi and is transmitted through the bite of infected ticks of the genus Ixodes.

According to the WHO, Lyme disease is more prominent in forested areas of Asia, north-western, central and eastern Europe, and the USA. Visitors to rural areas are more prone to infection with B. burgdorferi. Diagnosis of Lyme disease occurs as a two-tiered test where confirmation of Lyme disease by Western Blot is essential.

Reported cases indicate only patients suspected of having Lyme disease, whereas confirmed cases are the patients who tested positive in both diagnostic tests. Lyme Disease Tests is segmented into Lyme Disease Enzyme Immunoassay Test, Lyme Disease Western Blot Test, and Lyme Disease Other Tests.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Companies Mentioned

  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Meridian Bioscience Inc
  • Trinity Biotech Plc
  • DiaSorin SpA
  • Quidel Corp

Key Inclusions of the market model are:

Currently marketed Lyme Disease Tests and evolving competitive landscape

  • Insightful review of the key industry trends.
  • Annualized total Lyme Disease Tests market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, analysts provide unique country specific insights on the market.
  • SWOT analysis for Lyme Disease Tests market.
  • Competitive dynamics insights and trends provided for Lyme Disease Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Scope

  • CMO executives who must have deep understanding of the Lyme Disease Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

  • Understand the impact of COVID-19 on Lyme Disease Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Lyme Disease Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Lyme Disease Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Lyme Disease Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

For more information about this report visit https://www.researchandmarkets.com/r/8dzvrv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900